4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-26-040590
Chief Technology Officer acquired 350,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Louria Hayon Igal · Chief Technology Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-20 | Option exercise : show line 1 in the form | +350,000 | $0.01 | $3,500 | 1,349,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-20 | Option exercise : show line 2 in the form Warrants to purchase Common Stock | −350,000 | 0 | D |
Loading xslF345X06/ownership.xml…